FGF2 and congenital bilateral aplasia of vas deferens from CFTR mutation: Collectively, these results highlight the complex interactions between bFGF treatment, gene regulation through APA, and their implications in CAVD, underscoring the potential of bFGF as a modulator of disease progression.